Recombinant Factor VIII Production via Pichia pastoris Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant Factor VIII protein face challenges such as scarcity of plasma-derived sources, risk of viral contamination, and difficulty in expressing full-length recombinant Factor VIII, which are addressed by using the Pichia pastoris expression system to generate functional Factor VIII chains.
Innovation Solution
The process involves introducing polynucleotide sequences encoding the heavy and light chains of Factor VIII into Pichia pastoris, expressing and purifying these chains using IMAC and HLAC, and reconstituting them in the presence of divalent metal ions to produce a functional recombinant Factor VIII protein with improved activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If plasma-derived sources are used to produce Factor VIII protein, then the protein can be obtained through traditional purification methods, but the scarcity of plasma from healthy donors limits the quantity available for purification
Solution Approach 1:
The Factor VIII protein is divided into two separate chains (heavy chain and light chain) that are expressed independently in Pichia pastoris. This segmentation allows each chain to be produced separately and then reconstituted, overcoming the limitation of plasma scarcity by enabling scalable microbial expression of individual chains rather than relying on limited plasma sources.
Solution Approach 2:
Instead of purifying Factor VIII from natural plasma sources, the patent creates recombinant copies of the heavy and light chains using the Pichia pastoris expression system. This copying approach allows unlimited production of Factor VIII chains through microbial fermentation, independent of plasma donor availability.
2Reliability
If plasma-derived Factor VIII is purified, then treatment for Haemophilia A can be provided, but there is a risk of viral contamination
Solution Approach 1:
The patent produces recombinant Factor VIII chains in Pichia pastoris, creating a viral-free copy of the therapeutic protein. Since Pichia pastoris is a yeast system, it does not carry human viruses, thereby eliminating the viral contamination risk associated with plasma-derived products while providing the same therapeutic function.
Solution Approach 2:
The Pichia pastoris expression system serves as an intermediary host that produces Factor VIII chains without introducing viral contaminants. This intermediary microbial system allows safe production of human Factor VIII by separating the production process from human plasma sources.
3Reliability
If full-length recombinant Factor VIII is expressed, then complete Factor VIII activity can be achieved, but the expression is difficult due to the large size and complex structure
Solution Approach 1:
The full-length Factor VIII protein is segmented into heavy chain and light chain components that are expressed separately in Pichia pastoris. This segmentation reduces the complexity of expression for each individual chain, making manufacturing easier while maintaining the ability to reconstitute the complete functional protein.
Solution Approach 2:
The heavy and light chains are expressed and purified separately as preliminary steps before final reconstitution. This preliminary separation simplifies the expression process by avoiding the need to handle the complete complex protein structure during production, while ensuring both chains are available for assembly into the active heterodimer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method results in a recombinant Factor VIII protein with enhanced activity, overcoming the limitations of traditional production methods and providing a safer, more efficient alternative for treating Haemophilia A.
Implementation Method 1
introducing polynucleotide sequences encoding the heavy and light chains of Factor VIII into Pichia pastoris, expressing and purifying these chains
Implementation Method 2
purifying these chains using IMAC and HLAC
Implementation Method 3
purifying these chains using IMAC and HLAC
Implementation Method 4
reconstituting them in the presence of divalent metal ions to produce a functional recombinant Factor VIII protein
Data Source
Figure 1A~1B
Figure 2~3B
Figure 4A~4D
AI summary
The present disclosure relates specifically to a process of producing heavy chain peptide and/or light chain peptide of recombinant Factor VIII protein using Pichia pastoris expression system. The disclosure further relates to a process of producing a functional recombinant Factor VIII protein by reconstituting the Heavy chain and Light chain produced using said Pichia pastoris expression system. The said functional recombinant Factor VIII protein shows improved activity and therefore is used in the management of haemophilia.